Kiribati vs Lithuania: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Kiribati
87.0%
in 2025
Lithuania
87.0%
in 2025
Kiribati rank
86th
Lithuania rank
86th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Kiribati
- Lithuania
How they compare
Kiribati currently reports 87.0% against 87.0% in Lithuania, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Lithuania ahead.
Kiribati ranks 86th and Lithuania ranks 86th of 194 countries.
Kiribati has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kiribati | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 53.6% | 32.9% | 20.7% | Kiribati |
| 2020s | 90.5% | 83.7% | 6.8% | Kiribati |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Kiribati or Lithuania?
- Kiribati, at 87.0% against 87.0% in Lithuania as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Kiribati and Lithuania?
- 0.0%, with Kiribati ahead.
- How many years of comparable data are there for Kiribati and Lithuania?
- 18 years are reported by both, from 2008 to 2025.
- How do Kiribati and Lithuania rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Kiribati ranks 86th and Lithuania ranks 86th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.